Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment

Colon-targeted oral drug delivery systems (CDDSs) are desirable for the treatment of ulcerative colitis (UC), which is a disease with high relapse and remission rates associated with immune system inflammation and dysregulation localized within the lining of the large bowel. However, the success of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yipeng, Wang, Liying, Wang, Zi-Dan, Zhou, Quan, Zhou, Xuefei, Zhou, Tianhua, Guan, Yi-Xin, Liu, Xiangrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152766/
https://www.ncbi.nlm.nih.gov/pubmed/37127609
http://dx.doi.org/10.1186/s12951-023-01889-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152766/
https://www.ncbi.nlm.nih.gov/pubmed/37127609
http://dx.doi.org/10.1186/s12951-023-01889-0

Ejemplares similares